Prostate cancer and microRNAs: New insights into apoptosis.
暂无分享,去创建一个
A. Jalil | B. Farhood | Z. Aminov | J. Gupta | Fahad Alsaikhan | P. Ramaiah | Waleed K. Abdulsahib | Doaa Saadi Kareem | Ramirez-CoronelAndrés Alexis Ramírez-Coronel | Bagher Farhood
[1] H. Mirzaei,et al. Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma , 2023, Phytotherapy research : PTR.
[2] Michael R Hamblin,et al. Exosomal MicroRNA Profiling. , 2023, Methods in molecular biology.
[3] Michael R Hamblin,et al. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression , 2022, Frontiers in Cell and Developmental Biology.
[4] A. Shahini,et al. Long non-coding RNAs and melanoma: From diagnosis to therapy. , 2022, Pathology, research and practice.
[5] Michael R Hamblin,et al. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs , 2022, Frontiers in Cardiovascular Medicine.
[6] A. Khajavi,et al. The impact of conventional smoking versus electronic cigarette on the expression of VEGF, PEMPA1, and PTEN in rat prostate , 2022, Prostate international.
[7] Michael R Hamblin,et al. MicroRNA-383: A tumor suppressor miRNA in human cancer , 2022, Frontiers in Cell and Developmental Biology.
[8] Michael R Hamblin,et al. Non-coding RNAs and glioma: Focus on cancer stem cells , 2022, Molecular therapy oncolytics.
[9] Xiaoyi Huang,et al. MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis , 2022, Experimental & molecular medicine.
[10] Arash Salmaninejad,et al. Virus, Exosome, and MicroRNA: New Insights into Autophagy. , 2022, Advances in experimental medicine and biology.
[11] X. Zeng,et al. Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. , 2022, Pathology, research and practice.
[12] Michael R Hamblin,et al. Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers , 2022, Frontiers in Oncology.
[13] S. Freedland,et al. Statins and prostate cancer—hype or hope? The epidemiological perspective , 2022, Prostate Cancer and Prostatic Diseases.
[14] H. Mirzaei,et al. Interplays between non-coding RNAs and chemokines in digestive system cancers. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] Michael R Hamblin,et al. MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy , 2022, Molecular Neurobiology.
[16] Michael R Hamblin,et al. Cytokines and microRNAs in SARS-CoV-2: What do we know? , 2022, Molecular Therapy - Nucleic Acids.
[17] Wei Zhang,et al. Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p , 2022, Bioengineered.
[18] Tao Sun,et al. High miR-34a and miR-26b expressions inhibit prostate cancer cell OPCN-1 proliferation and enhances apoptosis , 2022, Tropical Journal of Pharmaceutical Research.
[19] Michael R Hamblin,et al. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma. , 2022, Epigenomics.
[20] Michael R Hamblin,et al. Microfluidics for detection of exosomes and microRNAs in cancer: State of the art , 2022, Molecular therapy. Nucleic acids.
[21] A. Khatami,et al. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease , 2022, The Brazilian Journal of Infectious Diseases.
[22] Y. Hsieh,et al. Targeting of Mcl-1 Expression by MiRNA-3614-5p Promotes Cell Apoptosis of Human Prostate Cancer Cells , 2022, International journal of molecular sciences.
[23] M. Moghoofei,et al. Human papilloma virus (HPV) and prostate cancer (PCa): The potential role of HPV gene expression and selected cellular MiRNAs in PCa development. , 2022, Microbial pathogenesis.
[24] F. Cheng,et al. MiR‐363‐3p promotes prostate cancer tumor progression by targeting Dickkopf 3 , 2022, Journal of clinical laboratory analysis.
[25] Sung-Hoon Kim,et al. BK002 Induces miR-192-5p-Mediated Apoptosis in Castration-Resistant Prostate Cancer Cells via Modulation of PI3K/CHOP , 2022, Frontiers in Oncology.
[26] Jian Sun,et al. Circ_0076305 facilitates prostate cancer development via sponging miR‐411‐5p and regulating PGK1 , 2022, Andrologia.
[27] Wenhui Zhao,et al. The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer Progression , 2022, Journal of oncology.
[28] Michael R Hamblin,et al. MicroRNA let-7 and viral infections: focus on mechanisms of action , 2022, Cellular & molecular biology letters.
[29] M. Aschner,et al. Quercetin and Glioma: Which signaling pathways are involved? , 2022, Current molecular pharmacology.
[30] Michael R Hamblin,et al. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis , 2021, Molecular therapy oncolytics.
[31] Xiao-hou Wu,et al. Long non-coding RNA lncHUPC1 induced by FOXA1 promotes tumor progression by inhibiting apoptosis via miR-133b/SDCCAG3 in prostate cancer. , 2022, American journal of cancer research.
[32] S. Niture,et al. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. , 2022, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[33] Michael R Hamblin,et al. Non-Coding RNAs and Brain Tumors: Insights Into Their Roles in Apoptosis , 2022, Frontiers in Cell and Developmental Biology.
[34] Y. Gong,et al. MiR-145-5p Inhibits the Invasion of Prostate Cancer and Induces Apoptosis by Inhibiting WIP1 , 2021, Journal of oncology.
[35] M. Aschner,et al. miRNA-148b and its role in various cancers. , 2021, Epigenomics.
[36] Ebru Temiz,et al. miR-19a and miR-421 target PCA3 long non-coding RNA and restore PRUNE2 tumor suppressor activity in prostate cancer , 2021, Molecular Biology Reports.
[37] Xisheng Wang,et al. Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA‐198 decoy , 2021, Andrologia.
[38] M. Akbari,et al. Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study. , 2021, Tissue & cell.
[39] A. Basiri,et al. The Role and Clinical Potentials of Circular RNAs in Prostate Cancer , 2021, Frontiers in Oncology.
[40] A. Bagherian,et al. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib. , 2021, Food & function.
[41] Michael R Hamblin,et al. MicroRNA-155 and antiviral immune responses. , 2021, International immunopharmacology.
[42] N. Sharma,et al. miR-221 regulates proliferation, invasion, apoptosis and progression of prostate cancer cells by modulating E-cadherin/Wnt/β catenin axis , 2021 .
[43] Michael R Hamblin,et al. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma , 2021, Frontiers in Cell and Developmental Biology.
[44] Michael R Hamblin,et al. Dysregulated expression of miRNAs in immune thrombocytopenia. , 2021, Epigenomics.
[45] M. Moghoofei,et al. Evaluation of the expression pattern of 4 microRNAs and their correlation with cellular/viral factors in PBMCs of Long Term non-progressors and HIV infected naïve Individuals. , 2021, Current HIV Research.
[46] D. Spratt,et al. Racial disparities in prostate cancer among black men: epidemiology and outcomes , 2021, Prostate Cancer and Prostatic Diseases.
[47] Jianquan Hou,et al. miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2 , 2021, World Journal of Surgical Oncology.
[48] B. Yousefi,et al. MiR‐622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer , 2021, Andrologia.
[49] Zhangren Yan,et al. miRNA-877-5p inhibits malignant progression of prostate cancer by directly targeting SSFA2 , 2021, European journal of histochemistry : EJH.
[50] M. Aschner,et al. Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles , 2021, EXCLI journal.
[51] Gonghui Li,et al. Role of noncoding RNA in drug resistance of prostate cancer , 2021, Cell Death & Disease.
[52] M. Aschner,et al. New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[53] Xiangxuan Zhao,et al. Targeting Bcl-2 for cancer therapy. , 2021, Biochimica et biophysica acta. Reviews on cancer.
[54] Michael R Hamblin,et al. Plant-based vaccines and cancer therapy: Where are we now and where are we going? , 2021, Pharmacological research.
[55] Jing Zhang,et al. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis , 2021, Drug design, development and therapy.
[56] Michael R Hamblin,et al. Angiogenesis-related non-coding RNAs and gastrointestinal cancer , 2021, Molecular therapy oncolytics.
[57] Michael R Hamblin,et al. Cell death pathways and viruses: Role of microRNAs , 2021, Molecular therapy. Nucleic acids.
[58] Daniel Lee. miR-769-5p is associated with prostate cancer recurrence and modulates proliferation and apoptosis of cancer cells , 2021, Experimental and therapeutic medicine.
[59] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[60] S. Kalantar,et al. Co-delivery of miRNA-15a and miRNA-16–1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells , 2021, Biotechnology Letters.
[61] P. Qi,et al. miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin , 2021, Cell death discovery.
[62] Nima Hemmat,et al. The role of Th17 cells in viral infections. , 2021, International immunopharmacology.
[63] Dong Chen,et al. Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells , 2021, Bioengineered.
[64] Yang Lifen,et al. miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway , 2021, The Libyan journal of medicine.
[65] Zhenhua Gu,et al. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways , 2021, Bioengineered.
[66] M. He,et al. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2 , 2021, Technology in cancer research & treatment.
[67] Michael R Hamblin,et al. Effects of therapeutic probiotics on modulation of microRNAs , 2020, Cell communication and signaling : CCS.
[68] Y. Niu,et al. Circ_0001686 Promotes Prostate Cancer Progression by Up-Regulating SMAD3/TGFBR2 via miR-411-5p , 2020, The world journal of men's health.
[69] M. Aschner,et al. Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players , 2021, Frontiers in Cardiovascular Medicine.
[70] M. Moghoofei,et al. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. , 2020, Microbial pathogenesis.
[71] Michael R Hamblin,et al. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. , 2020, Critical reviews in oncology/hematology.
[72] Qing-zuo Liu,et al. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis , 2020, Cancer biology & therapy.
[73] Zhirong Zhu,et al. MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2 , 2020, Experimental and therapeutic medicine.
[74] Yang Cheng,et al. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR-155 , 2020, Molecular medicine reports.
[75] Michael R Hamblin,et al. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect , 2020, Molecular therapy oncolytics.
[76] H. Mirzaei,et al. Circular RNAs: New players in thyroid cancer. , 2020, Pathology, research and practice.
[77] M. Ashrafizadeh,et al. Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers. , 2020, Pharmacological research.
[78] Michael R Hamblin,et al. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages , 2020, Cell communication and signaling : CCS.
[79] M. Darvish,et al. The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis. , 2020, International immunopharmacology.
[80] H. Mirzaei,et al. Circular RNA as a potential diagnostic and/or therapeutic target for endometriosis. , 2020, Biomarkers in medicine.
[81] Michael R Hamblin,et al. Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis. , 2020, Pathology, research and practice.
[82] H. Mirzaei,et al. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. , 2020, Pharmacological research.
[83] Biao Zhang,et al. LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1 , 2020, Cancer Cell International.
[84] Michael R Hamblin,et al. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis , 2020, Cell Communication and Signaling.
[85] Qin Li,et al. miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis , 2020, OncoTargets and therapy.
[86] Zhiqiang Duan,et al. miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway , 2020, Cancer management and research.
[87] Michael R Hamblin,et al. Circular RNAs: New Epigenetic Signatures in Viral Infections , 2020, Frontiers in Microbiology.
[88] Amin Jalili,et al. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. , 2020, Critical reviews in oncology/hematology.
[89] Michael R Hamblin,et al. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways , 2020, Journal of Molecular Neuroscience.
[90] Hong Zhang,et al. MicroRNA‑16‑5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells. , 2020, Oncology reports.
[91] M. Moghoofei,et al. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. , 2020, Microbial pathogenesis.
[92] Michael R Hamblin,et al. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus , 2020, Cell Communication and Signaling.
[93] M. Mansournia,et al. Circular RNAs: new genetic tools in melanoma. , 2020, Biomarkers in medicine.
[94] B. Baradaran,et al. MicroRNA-143 inhibits proliferation and migration of prostate cancer cells , 2020, Archives of physiology and biochemistry.
[95] Michael R Hamblin,et al. Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis , 2020, Molecular therapy. Nucleic acids.
[96] D. Del Bufalo,et al. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer , 2020, Cells.
[97] H. Zeng,et al. MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8 , 2020, Translational cancer research.
[98] J. Xing,et al. miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 , 2020, Cancer management and research.
[99] Z. Razavi,et al. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy , 2020, IUBMB life.
[100] W. El-Deiry,et al. Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.
[101] Hao Wang,et al. MicroRNA-337-3p suppresses cell viability, apoptosis, and autophagy by modulating PPARγ expression in androgen-dependent human prostate cancer , 2020 .
[102] Jiaqian Pan,et al. lncRNA ZFAS1 Is Involved in the Proliferation, Invasion and Metastasis of Prostate Cancer Cells Through Competitively Binding to miR-135a-5p , 2020, Cancer management and research.
[103] K. Abbaszadeh-Goudarzi,et al. Circular RNA and Diabetes: Epigenetic Regulator with Diagnostic role. , 2020, Current molecular medicine.
[104] Yan Cao,et al. LncRNA NEAT1 facilitates pancreatic cancer growth and metastasis through stabilizing ELF3 mRNA. , 2020, American journal of cancer research.
[105] Peng Wang,et al. SP1‐mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR‐377 to facilitate prostate cancer progression through regulation of ZIC5 , 2020, Journal of cellular physiology.
[106] Yingbo Ma,et al. LncRNA NEAT1 promotes autophagy via regulating miR‐204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma , 2020, Journal of cellular physiology.
[107] Y. Ghasemi,et al. The role of microRNAs in Lung Cancer: Implications for diagnosis and therapy. , 2020, Current molecular medicine.
[108] L. Hua,et al. MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression , 2019, Journal of cellular and molecular medicine.
[109] Michael R Hamblin,et al. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. , 2019, Critical reviews in oncology/hematology.
[110] Lei Wang,et al. Long noncoding RNA MIR22HG is down-regulated in prostate cancer. , 2019, Mathematical biosciences and engineering : MBE.
[111] Sheng-jie Guo,et al. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2 , 2019, Journal of experimental & clinical cancer research : CR.
[112] H. Mirzaei,et al. Role of resveratrol in modulating microRNAs in human diseases: From cancer to inflammatory disorder. , 2019, Current medicinal chemistry.
[113] Gonghui Li,et al. lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143 , 2019, Molecular therapy. Nucleic acids.
[114] B. Schilling,et al. miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1 , 2019, BioMed research international.
[115] Shaoxiong Zhao,et al. miR‐4286 promotes prostate cancer progression by targeting the expression of SALL1 , 2019, The journal of gene medicine.
[116] R. Ray,et al. miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression , 2019, Cells.
[117] Michael R Hamblin,et al. miRNAs derived from cancer-associated fibroblasts in colorectal cancer. , 2019, Epigenomics.
[118] Ji-Ping Wang,et al. MicroRNA‐498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN , 2019, The Kaohsiung journal of medical sciences.
[119] Michael R Hamblin,et al. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review , 2019, International journal of cancer.
[120] A. Avan,et al. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. , 2019, Pathology, research and practice.
[121] Y. Ghasemi,et al. Electrochemical-based biosensors for microRNA detection: Nanotechnology comes into view. , 2019, Analytical biochemistry.
[122] N. Sharifi,et al. Anti-cancer effects of cinnamon: Insights into its apoptosis effects. , 2019, European journal of medicinal chemistry.
[123] Y. Ghasemi,et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer , 2019, Journal of Ovarian Research.
[124] Rajesh Singh,et al. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway , 2019, Cancers.
[125] F. Boccardo,et al. Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer , 2019, Cancers.
[126] P. Tassone,et al. Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma , 2019, Leukemia.
[127] Ying Shi,et al. Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3 , 2019, Molecular therapy. Nucleic acids.
[128] Yin Liu,et al. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway , 2019, Journal of Biosciences.
[129] Jiajie Fang,et al. Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4 , 2019, Cancer medicine.
[130] Bing Zhong,et al. miR‑589‑5p is downregulated in prostate cancer and regulates tumor cell viability and metastasis by targeting CCL‑5. , 2019, Molecular medicine reports.
[131] P. Duijf,et al. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. , 2019, Free radical biology & medicine.
[132] S. Patra,et al. miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability. , 2019, Gene.
[133] Guoan Chen,et al. LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling , 2019, Aging.
[134] R. Dahiya,et al. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells , 2019, Scientific Reports.
[135] S. Niture,et al. Abstract 3561: MicroRNA-214 inhibits prostate cancer cell proliferation, migration, invasion and increases drug sensitivity by targeting PTK6 , 2019, Molecular and Cellular Biology / Genetics.
[136] Yi Zhou,et al. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4 , 2019, Cell Death & Disease.
[137] Chen Fang,et al. MicroRNA-145 inhibits proliferation and induces apoptosis in human prostate carcinoma by upregulating long non-coding RNA GAS5 , 2019, Oncology letters.
[138] Yuqi Wu,et al. MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells. , 2019, Molecular medicine reports.
[139] Jiangui Lin,et al. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19. , 2019, Gene.
[140] Yi Lu,et al. Effect of miR-200c on proliferation, invasion and apoptosis of prostate cancer LNCaP cells , 2019, Oncology letters.
[141] Shenglin Huang,et al. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR‐10a‐5p/NCOR2 axis in hepatocellular carcinoma cells , 2019, Cancer science.
[142] Can Wang,et al. MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway , 2019, Cancer medicine.
[143] Sang Kook Lee,et al. Circular RNAs in Cancer , 2019, Molecular therapy. Nucleic acids.
[144] G. Azizi,et al. The role of microRNAs in prostate cancer migration, invasion, and metastasis , 2018, Journal of cellular physiology.
[145] Lihua Zhang,et al. MicroRNA-135a induces prostate cancer cell apoptosis via inhibition of STAT6. , 2018, Oncology letters.
[146] P. Codoñer-Franch,et al. Molecular aspects of pancreatic β‐cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA , 2018, Journal of cellular physiology.
[147] H. Mirzaei,et al. Role of microRNAs in chronic lymphocytic leukemia pathogenesis. , 2019, Current medicinal chemistry.
[148] H. Mirzaei,et al. Long Non-Coding RNAs: Epigenetic Regulators in Cancer. , 2019, Current pharmaceutical design.
[149] Y. Wen,et al. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5. , 2019, Cancer biomarkers : section A of Disease markers.
[150] Ren-Zong Chen,et al. miR-448 inhibits proliferation and induces apoptosis in prostate cancer cells by modulating cyclin-dependent kinase 19 expression , 2019 .
[151] Yifan Liu,et al. MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[152] Reza Salarinia,et al. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer. , 2019, Critical reviews in eukaryotic gene expression.
[153] H. Qin,et al. miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells. , 2018, American journal of cancer research.
[154] B. You,et al. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55. , 2018, European review for medical and pharmacological sciences.
[155] W. Nahas,et al. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[156] T. Zhu,et al. Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer , 2018, Cellular Physiology and Biochemistry.
[157] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[158] X. Li,et al. KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer , 2018, Cell Communication and Signaling.
[159] S. Khan,et al. miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy , 2018, Cancers.
[160] Xunbo Jin,et al. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells. , 2018, Oncology research.
[161] Weijie Cheng,et al. MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55. , 2018, American journal of translational research.
[162] Ghazal Haddad,et al. miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines , 2018, Asian Pacific journal of cancer prevention : APJCP.
[163] Ronggang Li,et al. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling , 2018, Journal of experimental & clinical cancer research : CR.
[164] M. Wiesehöfer,et al. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells , 2018, PloS one.
[165] F. Fu,et al. Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer. , 2018, Gene.
[166] Fei Yang,et al. miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. , 2018, Experimental and therapeutic medicine.
[167] S. Mousavi,et al. MicroRNAs and exosomes in depression: Potential diagnostic biomarkers , 2018, Journal of cellular biochemistry.
[168] H. Mirzaei,et al. Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker , 2018, Journal of cancer research and therapeutics.
[169] G. Dong,et al. Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer. , 2018, International journal of molecular medicine.
[170] K. Horie-Inoue,et al. Prostate cancer-associated lncRNAs. , 2018, Cancer letters.
[171] H. Mirzaei,et al. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers , 2018, Journal of cellular physiology.
[172] N. Chen,et al. MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components , 2018, The Prostate.
[173] Y. Shao,et al. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[174] Amareshwar T. K. Singh,et al. Apoptosis: A Target for Anticancer Therapy , 2018, International journal of molecular sciences.
[175] H. Mirzaei,et al. MiR‐21: A key player in glioblastoma pathogenesis , 2018, Journal of cellular biochemistry.
[176] A. Avan,et al. GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma , 2018, Journal of cellular physiology.
[177] Hamed Mirzaei,et al. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer , 2018, Journal of cellular physiology.
[178] J. Stenvang,et al. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia , 2018, Journal of cellular physiology.
[179] S. Kouhpayeh,et al. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy , 2018, Journal of cellular physiology.
[180] P. Codoñer-Franch,et al. Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome , 2018, Journal of cellular biochemistry.
[181] Zhongmin Zhang,et al. MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-κB signaling pathway activation , 2018, Oncology letters.
[182] Mohsen Poursadeghiyan,et al. Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes , 2018, Journal of cellular biochemistry.
[183] Junhua Zheng,et al. microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[184] Dan Wang,et al. MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression , 2017, Oncotarget.
[185] D. Green,et al. MOMP, cell suicide as a BCL-2 family business , 2017, Cell Death and Differentiation.
[186] Bahman Rashidi,et al. MicroRNA: A novel target of curcumin in cancer therapy , 2017, Journal of cellular physiology.
[187] Qiang Zhou,et al. Enhanced expression of miR-375 increases chemotherapy sensitivity of prostate cancer to cisplatin , 2018 .
[188] Xiaobin Zhang,et al. miRNA-627 inhibits cell proliferation and cell migration, promotes cell apoptosis in prostate cancer cells through upregulating MAP3K1, PTPRK and SRA1. , 2018, International journal of clinical and experimental pathology.
[189] A. Panda. Circular RNAs Act as miRNA Sponges. , 2018, Advances in experimental medicine and biology.
[190] W. Xiong,et al. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway. , 2018, The international journal of biochemistry & cell biology.
[191] Lei Chen,et al. MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1 , 2018, World Journal of Urology.
[192] Yanling Zhao,et al. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy , 2017, Oncotarget.
[193] H. Mirzaei. Stroke in Women: Risk Factors and Clinical Biomarkers , 2017, Journal of cellular biochemistry.
[194] Shuxia Wang,et al. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer. , 2017, International journal of biological macromolecules.
[195] Zhen Liang,et al. MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway , 2017, Oncotarget.
[196] Y. Hsieh,et al. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells. , 2017, Biochimica et biophysica acta. Molecular cell research.
[197] T. Hwang,et al. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. , 2017, Asian journal of surgery.
[198] W. Zhong,et al. miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein , 2017, Molecular medicine reports.
[199] Hui Wang,et al. Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling. , 2017, Urology.
[200] J. Arbiser,et al. Targeting the duality of cancer , 2017, npj Precision Oncology.
[201] C. Collins,et al. miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer , 2017, Scientific Reports.
[202] Weifeng Yu,et al. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. , 2017, Oncology reports.
[203] O. Ogunwobi,et al. A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer. , 2017, RNA & disease.
[204] Yu-jie Wang,et al. MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression. , 2017, Biochemical and biophysical research communications.
[205] Zhiwei Ma,et al. miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[206] Yeqing Huang,et al. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling , 2017, Oncotarget.
[207] G. Stein,et al. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2 , 2017, Cell Death and Disease.
[208] Weidong Zhou,et al. Suppression of miR-4735-3p in androgen receptor-expressing prostate cancer cells increases cell death during chemotherapy. , 2017, American journal of translational research.
[209] Jian Wang,et al. microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1). , 2017, American journal of translational research.
[210] A. Avan,et al. Cytokines and MicroRNA in Coronary Artery Disease. , 2017, Advances in clinical chemistry.
[211] S. Mousavi,et al. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers , 2016, Cancer Gene Therapy.
[212] Yongxing Wang,et al. Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line. , 2016, Oncology reports.
[213] Jianguo Huang,et al. Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2. , 2016, Oncology letters.
[214] R. Salehi,et al. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies. , 2016, Current cancer drug targets.
[215] A. Avan,et al. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. , 2016, Current medicinal chemistry.
[216] M. Jaafari,et al. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma , 2016, Cancer Gene Therapy.
[217] Shu Yang,et al. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression. , 2016, The international journal of biochemistry & cell biology.
[218] A. Sahebkar,et al. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia , 2016, Cancer Gene Therapy.
[219] Yeqing Huang,et al. miRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer. , 2016, Molecular medicine reports.
[220] Mohammad Jafari,et al. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. , 2016, Current pharmaceutical design.
[221] K. D. Sørensen,et al. The Potential of MicroRNAs as Prostate Cancer Biomarkers. , 2016, European urology.
[222] A. Hamid,et al. The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. , 2016, Acta medica Indonesiana.
[223] Yongning Sun,et al. Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301 , 2016, OncoTargets and therapy.
[224] Yue Wang,et al. Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway. , 2016, Biochemical and biophysical research communications.
[225] M. Harada,et al. Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells , 2016, International journal of oncology.
[226] Lina Chen,et al. MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer. , 2016, Molecular medicine reports.
[227] Yuxin Tang,et al. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway. , 2016, Oncology reports.
[228] A. Avan,et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. , 2015, Current pharmaceutical design.
[229] A. Avan,et al. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. , 2016, European journal of cancer.
[230] Hong Zhang,et al. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells , 2016, Tumor Biology.
[231] Zhe Zhang,et al. MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo , 2016, Tumor Biology.
[232] C. Tepper,et al. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. , 2015, Cancer research.
[233] M. G. Paulraj,et al. MicroRNA in prostate cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[234] Yeqing Huang,et al. Hsa‐miR‐146a‐5p modulates androgen‐independent prostate cancer cells apoptosis by targeting ROCK1 , 2015, The Prostate.
[235] Peng-ju Zhang,et al. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. , 2015, Gene.
[236] T. Deguchi,et al. miR‐130a activates apoptotic signaling through activation of caspase‐8 in taxane‐resistant prostate cancer cells , 2015, The Prostate.
[237] C. Perez-stable,et al. Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage , 2015, Oncoscience.
[238] Jianxin Diao,et al. Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution , 2015, Oncotarget.
[239] Jing Yang,et al. RLIP76-dependent suppression of PI3K/AKT/Bcl-2 pathway by miR-101 induces apoptosis in prostate cancer. , 2015, Biochemical and biophysical research communications.
[240] Bo Jiang,et al. Role of MicroRNAs in Prostate Cancer Pathogenesis. , 2015, Clinical genitourinary cancer.
[241] Zlatko Trajanoski,et al. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. , 2015, Molecular endocrinology.
[242] Yiduo Wang,et al. MicroRNA‐19a regulates proliferation and apoptosis of castration‐resistant prostate cancer cells by targeting BTG1 , 2015, FEBS letters.
[243] C. Creighton,et al. Overexpression of miR-145–5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression , 2015, Cancer investigation.
[244] Xuechao Wan,et al. MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation. , 2015, International journal of clinical and experimental medicine.
[245] S. Tait,et al. Mitochondrial apoptosis: killing cancer using the enemy within , 2015, British Journal of Cancer.
[246] Xinjun Zhang,et al. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression. , 2015, Biochemical and biophysical research communications.
[247] Jianxiang Wang,et al. MicroRNA regulation and therapeutic targeting of survivin in cancer. , 2015, American journal of cancer research.
[248] Eugenia G. Giannopoulou,et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.
[249] G. Jeschke,et al. Structural model of active Bax at the membrane. , 2014, Molecular cell.
[250] Sung-Hoon Kim,et al. Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis , 2014, Oncotarget.
[251] G. Tonon,et al. RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS , 2014, Nature Medicine.
[252] R. Dahiya,et al. Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer , 2014, Molecular Cancer Therapeutics.
[253] M. Hsiao,et al. MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo , 2014, Oncogenesis.
[254] Jingqiang Wang,et al. Identification of miR-133b and RB1CC1 as Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer , 2014, Clinical Cancer Research.
[255] Lei Zhang,et al. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). , 2014, Biochemical and biophysical research communications.
[256] K. Riabowol,et al. Survivin as a Preferential Target for Cancer Therapy , 2014, International journal of molecular sciences.
[257] L. Feng,et al. Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells , 2014, Leukemia.
[258] Y. Harazono,et al. Why anti-Bcl-2 clinical trials fail: a solution , 2014, Cancer and Metastasis Reviews.
[259] Peter E. Czabotar,et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.
[260] Qun Liu,et al. MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells , 2013, BMC Complementary and Alternative Medicine.
[261] C. Stephan,et al. The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1 , 2013, PloS one.
[262] B. V. Chakravarthi,et al. Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani , 2013, Cancer Cell International.
[263] Anna L. Walsh,et al. Noncoding RNAs in Prostate Cancer: The Long and the Short of It , 2013, Clinical Cancer Research.
[264] M. Mourtada-Maarabouni,et al. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. , 2013, Biochimica et biophysica acta.
[265] C. Tepper,et al. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells , 2013, Oncogene.
[266] C. Qin,et al. miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. , 2013, Asian journal of andrology.
[267] Jayoung Kim,et al. MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells , 2013, PloS one.
[268] Dong Xu,et al. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. , 2013, Molecular medicine reports.
[269] Markus Vogt,et al. MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. , 2013, International journal of oncology.
[270] Li Wang,et al. MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[271] Randy S. Schrecengost,et al. Molecular pathogenesis and progression of prostate cancer. , 2013, Seminars in oncology.
[272] D. Altieri. Targeting survivin in cancer. , 2013, Cancer letters.
[273] H. Kung,et al. Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer , 2013, PloS one.
[274] S. Majid,et al. The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression , 2013, Journal of the National Cancer Institute.
[275] G. Wahl,et al. MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.
[276] Kang Han,et al. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. , 2012, Oncology reports.
[277] Michael V. Fiandalo,et al. Caspase control: protagonists of cancer cell apoptosis. , 2012, Experimental oncology.
[278] N. Saini,et al. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis – a combined computational and experimental approach , 2012, Journal of Cell Science.
[279] A. Schäffer,et al. The phenotype of human STK4 deficiency. , 2011, Blood.
[280] Rebecca SY Wong,et al. Apoptosis in cancer: from pathogenesis to treatment , 2011, Journal of experimental & clinical cancer research : CR.
[281] H. Lähdesmäki,et al. The miR‐15a‐miR‐16‐1 locus is homozygously deleted in a subset of prostate cancers , 2011, Genes, chromosomes & cancer.
[282] R. Dahiya,et al. The functional significance of microRNA-145 in prostate cancer , 2010, British Journal of Cancer.
[283] H. Lilja,et al. miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions , 2010, International journal of cancer.
[284] Rajvir Dahiya,et al. MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer , 2010, Cancer.
[285] Qunshu Zhang,et al. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells , 2010, Cell Death and Disease.
[286] Jianyuan Luo,et al. SIRT1 and p53, effect on cancer, senescence and beyond. , 2010, Biochimica et biophysica acta.
[287] Liang Xu,et al. Chemosensitization of prostate cancer by modulating Bcl-2 family proteins. , 2010, Current drug targets.
[288] Huiqing Yuan,et al. MicroRNAs and prostate cancer. , 2010, Acta biochimica et biophysica Sinica.
[289] Subbaya Subramanian,et al. MicroRNAs as gatekeepers of apoptosis , 2010, Journal of cellular physiology.
[290] C. Croce,et al. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.
[291] R. M. Simpson,et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression , 2010, Proceedings of the National Academy of Sciences.
[292] Osamu Takeuchi,et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. , 2009, Molecular cell.
[293] Jeannie T. Lee,et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.
[294] M. Hsiao,et al. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation , 2009, Oncogene.
[295] P. Sun,et al. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. , 2009, Biochemical and biophysical research communications.
[296] G. Gores,et al. Life and death by death receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[297] B. Lin,et al. Effect of miR-296 on the Apoptosis of Androgen-independent Prostate Cancer Cells , 2009 .
[298] W. Gu,et al. How does SIRT1 affect metabolism, senescence and cancer? , 2009, Nature Reviews Cancer.
[299] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[300] Yasunori Fujita,et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. , 2008, Biochemical and biophysical research communications.
[301] D. Andrews,et al. Bid: a Bax-like BH3 protein , 2008, Oncogene.
[302] Mauro Biffoni,et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.
[303] John Calvin Reed,et al. Bcl-2 family proteins and cancer , 2008, Oncogene.
[304] D. Bumcrot,et al. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer , 2008, Cancer biology & therapy.
[305] T. Fan,et al. Inhibitor of apoptosis proteins and apoptosis. , 2008, Acta biochimica et biophysica Sinica.
[306] A. Strasser,et al. The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.
[307] W. Fairbrother,et al. The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer , 2007, Clinical Cancer Research.
[308] W. Jetz,et al. Global patterns and determinants of vascular plant diversity , 2007, Proceedings of the National Academy of Sciences.
[309] M. Jovanović,et al. miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.
[310] S. Armstrong,et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.
[311] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[312] N. Kyprianou,et al. Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance , 2006, Journal of cellular biochemistry.
[313] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[314] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[315] A. Safa,et al. Taxol Induces Caspase-10-dependent Apoptosis* , 2004, Journal of Biological Chemistry.
[316] Mark F McCarty,et al. Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy , 2004, Integrative cancer therapies.
[317] Peizhang Xu,et al. MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.
[318] Gangduo Wang,et al. Apoptosis in prostate cancer: progressive and therapeutic implications (Review). , 2004, International journal of molecular medicine.
[319] D. Stern. More than a Marker… Phosphorylated Akt in Prostate Carcinoma , 2004, Clinical Cancer Research.
[320] D. Hallahan,et al. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer , 2004, Oncogene.
[321] K. Do,et al. Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer , 2004, Clinical Cancer Research.
[322] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[323] H. Klocker,et al. Long‐term androgen‐ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells , 2004, The Prostate.
[324] Min Chen,et al. Initiator caspases in apoptosis signaling pathways , 2002, Apoptosis.
[325] Inmaculada Hernández,et al. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. , 2003, Molecular cancer research : MCR.
[326] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[327] Wenhua Gao,et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. , 2003, Genes & development.
[328] T. McDonnell,et al. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma , 2003, Cancer.
[329] Joanna K. Sax,et al. BID regulation by p53 contributes to chemosensitivity , 2002, Nature Cell Biology.
[330] Mason R. Mackey,et al. Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.
[331] Y. Whang,et al. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway , 2002, Oncogene.
[332] Wafik S El-Deiry,et al. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. , 2002, Neoplasia.
[333] H. Chun,et al. Caspase-10 is an initiator caspase in death receptor signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[334] T. Ohyama,et al. MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation* , 2001, The Journal of Biological Chemistry.
[335] Miguel Srougi,et al. Abnormal Expression of MDM2 in Prostate Carcinoma , 2001, Modern Pathology.
[336] K. Vousden,et al. PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.
[337] G. Rodan,et al. Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis , 1999, The Journal of Biological Chemistry.
[338] P. Biberfeld,et al. The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.
[339] M. Ultsch,et al. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. , 1999, Molecular cell.
[340] W. Yung,et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. , 1999, Cancer research.
[341] A. Borkowski,et al. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. , 1998, Urology.
[342] L. Hood,et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. , 1997, Immunity.
[343] J. Tschopp,et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.
[344] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[345] Manuel C. Peitsch,et al. Characterization of Fas (Apo-1, CD95)-Fas Ligand Interaction* , 1997, The Journal of Biological Chemistry.
[346] R. Weichselbaum,et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[347] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[348] D. McConkey,et al. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. , 1996, Cancer research.
[349] Stephen W. Fesik,et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain , 1996, Nature.
[350] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[351] John Calvin Reed,et al. Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*) , 1996, The Journal of Biological Chemistry.
[352] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[353] W. W. Nichols,et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. , 1993, Journal of the National Cancer Institute.
[354] D. Chopin,et al. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.
[355] M. Campbell,et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.
[356] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.